论文部分内容阅读
肝功能障碍时,在临床上屡见有高血糖、低血糖等糖代谢异常,它与原发性糖尿病的鉴别常有困难。本文观察三组患者(肝硬化25例、糖尿病13例,糖尿病伴肝硬化9例)及对照组(5例)静脉葡萄糖耐量试验(IVGTT)。以40%葡萄糖50毫升在2分钟内静注,在注前及注后3,5,10,30,60分钟测血糖值(葡萄糖氧化酶法)及血免疫反应胰岛素(IRI)的变化,以明确肝硬化糖耐量异常的病理生理机制。结果:[1]IVGTT中血糖值:注射后3分钟血糖平均值,糖尿病组显著高于对照组与肝硬化组。而对照组、肝硬化组,糖尿病伴肝硬化组之间无显著差
Liver dysfunction, often clinically high blood sugar, hypoglycemia and other abnormal glucose metabolism, it is often difficult to identify with primary diabetes. We observed three groups of patients (cirrhosis 25, diabetes 13, diabetes with cirrhosis 9) and control group (5) intravenous glucose tolerance test (IVGTT). The rats were intravenously injected with 50 ml of 40% glucose for 2 minutes, and the changes of blood glucose (glucose oxidase) and blood-insulin (IRI) were measured before and 3, 5, 10, 30, Clear cirrhosis of impaired glucose tolerance pathophysiology. Results: [1] Blood glucose levels in IVGTT: Mean blood glucose 3 minutes after injection, diabetic group was significantly higher than the control group and cirrhosis group. The control group, cirrhosis, diabetic patients with cirrhosis was not significantly different